In this issue:
Benefits and risks of iron interventions in infants
Mycophenolate mofetil for first-line treatment of ITP
Tretinoin + high-dose dexamethasone for newly diagnosed ITP
Upfront SCT vs. pretransplant cytoreduction in advanced MDS
Imetelstat for relapsed/refractory myelofibrosis
Rituximab + belimumab for persistent or chronic ITP
Association of insufficient plasma exchange with fatal outcome in immune-mediated TTP
Peripheral cytopenias with ageing and haematological disease/mortality risk
Long-term outcome with ibrutinib for Waldenström macroglobulinaemia
Post-thrombotic syndrome with dabigatran vs. warfarin for VTE
Please login below to download this issue (PDF)